Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Emeritus Professor Ian Frazer
University of Queensland
The future of cancer and medical research
In this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:
- Inventing the technology behind the world’s first cancer vaccine
- Vaccine hesitancy, and the potential of other vaccines for cancer
- What makes the Translational Research Institute so special
- The interface between clinicians, scientists and patients in medical research
- Our expanding understanding of cancer and targeted treatment
- The experience of being Australian of The Year, and what he’s working on now
- How the Medical Research Future Fund works
- The alleged brain drain of medical researchers from Australia
- The need to better embed medical research into the health system
- How he sees medical research benefiting patients in 10 years’ time
More about Emeritus Professor Ian Frazer
Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.
He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.
Ce que les auditeurs disent de Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.